Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage: A safety analysis

Cerebrovascular Diseases

Volumn 27, Issue 2, 2009, Pages 146-150

  Kiphuth, Ines C ^a   Staykov, Dimitre ^a   Köhrmann, Martin ^a   Struffert, Tobias ^a   Richter, Gregor ^a   Bardutzky, Jürgen ^a   Kollmar, Rainer ^a   Mäurer, Mathias ^a   Schellinger, Peter D ^a   Hilz, Max Josef ^a   Doerfler, Arnd ^a   Schwab, Stefan ^a   Huttner, Hagen B ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Hematoma growth; Heparin; Intracerebral hemorrhage

Indexed keywords

DALTEPARIN; ENOXAPARIN; HIRUDIN;

ADULT; AGED; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DRUG SAFETY; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL ADMISSION; HUMAN; LUNG EMBOLISM; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROPHYLAXIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; FEMALE; HEMATOMA; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 56749165390     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000177923     Document Type: Article

References (28)

1. Adams HP Jr, del Zoppo G, Alberts MJ, et al: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-1711.
2. Gubitz G, Sandercock P, Counsell C: Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2004;CD000024.
3. Sandercock P, Counsell C, Stobbs SL: Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database Syst Rev 2005;CD000119.
4. Geerts WH, Pineo GF, Heit JA, et al: Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(suppl):S338-S400.
5. Wijdicks EF, Scott JP: Pulmonary embolism associated with acute stroke. Mayo Clin Proc 1997;72:297-300.
6. Diener HC, Ringelstein EB, von Kummer R, et al: Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial. Stroke 2006;37:139-144.
7. Clagett GP, Anderson FA Jr, Heit J, Levine MN, Wheeler HB: Prevention of venous thromboembolism. Chest 1995;108(suppl):S312-S334.
8. Sherman DG, Albers GW, Bladin C, et al: The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet 2007;369:1347-1355.
9. Broderick J, Connolly S, Feldmann E, et al: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38:2001-2023.
10. Skaf E, Stein PD, Beemath A, Sanchez J, Bustamante MA, Olson RE: Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol 2005;96:1731-1733.
11. Maramattom BV, Weigand S, Reinalda M, Wijdicks EF, Manno EM: Pulmonary complications after intracerebral hemorrhage. Neurocrit Care 2006;5:115-119.
12. Gregory PC, Kuhlemeier KV: Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil 2003;82:364-369.
13. Mayer SA, Brun NC, Begtrup K, et al: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-785.
14. Lacut K, Bressollette L, Le Gal G, et al: Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 2005;65:865-869.
15. Boeer A, Voth E, Henze T, Prange HW: Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1991;54:466-467.
16. Dickmann U, Voth E, Schicha H, Henze T, Prange H, Emrich D: Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage. Klin Wochenschr 1988;66:1182-1183.
17. Kleindienst A, Harvey HB, Mater E, et al: Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochir (Wien) 2003;145:1085-1090, discussion 1090-1081.
18. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T: Enlargement of spontaneous intracerebral hemorrhage: incidence and time course. Stroke 1996;27:1783-1787.
19. Lim JK, Hwang HS, Cho BM, et al: Multivariate analysis of risk factors of hematoma expansion in spontaneous intracerebral hemorrhage. Surg Neurol 2008;69:40-45.
20. Browd SR, Ragel BT, Davis GE, Scott AM, Skalabrin EJ, Couldwell WT: Prophylaxis for deep venous thrombosis in neurosurgery: suggested DVT prevention guidelines. Neurosurg Focus 2004;17:E1.
21. Steiner T, Kaste M, Forsting M, et al: Recommendations for the management of intracranial haemorrhage. 1. Spontaneous intracerebral haemorrhage: the European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006;22:294-316.
22. Kothari RU, Brott T, Broderick JP, et al: The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996;27:1304-1305.
23. Huttner HB, Steiner T, Hartmann M, et al: Comparison of ABC/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhage. Stroke 2006;37:404-408.
24. Zimmerman RD, Maldjian JA, Brun NC, Horvath B, Skolnick BE: Radiologic estimation of hematoma volume in intracerebral hemorrhage trial by CT scan. AJNR Am J Neuroradiol 2006;27:666-670.
25. Brott T, Broderick J, Kothari R, et al: Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28:1-5.
26. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J: Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004;63:1059-1064.
27. Audebert HJ, Schenk B, Tietz V, Schenkel J, Heuschmann PU: Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment. Cerebrovasc Dis 2008;26:171-177.
28. Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G: A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med 2000;160:181-188.